New partnerships announced

BioMérieux - Clinical field

A global leader in in vitro diagnostics for more than 55 years, bioMérieux has always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide.

The Company is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. It provides diagnostic solutions that improve patient health and ensure consumer safety.

bioMérieux develops and produces in vitro diagnostic solutions (systems, reagents, software and services) for private laboratories and also public hospital laboratories.

bioMerieux - Industry field

Leader in innovative diagnostic solutions for industry, bioMérieux has applied over the past 25 years the experience gained in the clinical sector to meet the needs of industrial microbiology, providing innovative and precise technology to support the food industry, the pharmaceutical and cosmetics industry, at every step of the production process, so that our customers can keep up to date and the high quality of manufactured products, while increasing the level of productivity.

ProGnosis Biotech is a European Biotech company specialized in Elisa & Lateral Flow Test with one and sole goal: to provide solutions with cutting-edge diagnostics tests. ProGnosis Biotech provides simple and precise solutions to meet the needs of the food and feed industry, to achieve decisive results in a limited time. The goal of Prognosis Biotech is precision through innovation, investing in providing reliable and innovative immunological tests that carry unprecedented characteristics in terms of accuracy, sensitivity and stability.

With over 50 years of experience, Microbiologics' mission is to provide the highest quality biomaterials for a safer and healthier world.

Microbiologics provides microorganisms for quality control in the clinical, pharmaceutical and cosmetic, food, water and education fields. The products are manufactured in accordance with the highest industry standards, obtaining ISO 13485 certification, as well as ISO 17025 and ISO 17034 accreditation.

DIAGAST was founded within the Center Régional de Transfusion Sanguine (Regional Blood Transfusion Center) in Lille in 1968. Its role consisted of manufacturing reagents capable of determining blood groups for patients who needed blood transfusions, as well as for the blood used in transfusions. Later, the laboratory invented a wide range of revolutionary reagents (monoclonal reagents) for which it is the exclusive agent.

Over the last 30 years, DIAGAST has developed unique expertise and know-how in the transfusion sector. These values allow healthcare professionals to insure the total transfusional compatibility between receivers and donors. Thus DIAGAST has combined biology with information technology, to make its equipment evolving in parallel with the best of the new technology.

Our company develops, produces and markets reagents and automated systems (QWALYS) for the blood grouping determination. Thanks to its mastering of the value chain (from R&D to the installation of solutions including customer training) DIAGAST is able to offer reliable solutions tailored to the needs and requirements of its customers.

Fujirebio - is a company part of H.U. Group, a global Japanese healthcare player that favors cross-group R&D synergies and expertise in clinical laboratory testing (SRL), IVD testing solutions (Fujirebio) and other specialized healthcare related activities.

As part of H.U. Group, it has the capacity to truly understand patient needs and we collaborate closely with clinicians and laboratorians worldwide to develop innovative IVD testing solutions for today and tomorrow.

Tosoh Bioscience has throughout the years demonstrated Technological Leadership in a number of Diagnostics niche markets including Immunochemistry, HPLC based diabetes and thalassemia screening and Molecular Biology.

This leadership is based on an in-depth understanding of the ever growing clinical demand for faster and more precise diagnosis of a number of life threatening pathologies (e.g. tumour, cardiac, diabetes etc).

But Tosoh Bioscience is not only about Technology: Tosoh Bioscience understands the requirement for second-to-none excellence in Customer Support and Customer Service.

RANDOX is one of the leading manufacturers of Biochip Array technology, ELISA, laboratory reagents, quality control, laboratory software, external control schemes and automated systems for clinical biochemistry, forensics and toxicology.

            The main goal is to improve medical services globally through innovative diagnostic technologies for a range of diseases, including heart disease, diabetes, Alzheimer's, cancer, stroke, etc.

Around 70% of all medical decisions are based on laboratory results, we believe that early and accessible diagnosis is the key to improving global health and saving lives.

• 10% of globally tested clinical chemistry tests are performed with Randox support.
• Randox External Control Schemes (EQA) - is the most widely used globally
• Manufacturer of unique tests
• 25% of companies revenue is permanently invested in research and development
• The largest biochip test panel -> 500 different types of tests

RANDOX FOOD DIAGNOSTICS

Randox Food Diagnostics is an associate of Randox Laboratories Ltd., with over 35 years of experience in the diagnostic market, being oriented towards the development of new products for antibiotic residue screening, growth hormones, drug abuse in animals and in food products, mycotoxin testing. 

Randox also provides kits and analyzers for wine and honey testing.

Adaltis S.r.l. is an international IVD company headquartered in Rome, Italy and provides High Quality Innovative and Reliable IVD Systems & Automated Clinical Diagnostic Analysers Reagent Kits & Controls

The company develops, manufactures and markets fully automated systems and wide range of RT-PCR testing reagent kits for the Molecular Diagnostic / RT-PCR testing and extraction and purification platform RCR systems.

Urit - is one of the first IVD companies in China to become the market leader in urinalysis and hematology equipment. Provides solutions for hospitals, laboratories, medical and veterinary offices, the company being present in over 100 countries.

With over 20% of employees active in R&D, Urit permanently invests in development over 15% of its revenues, thus allowing access to technology and permanent product improvement for final partners.

IDEXX is a leader in water microbiology, providing testing for safe drinking water and other water sources for more than 100 billion people in 100 countries globally.

In the field of animal and chicken production, IDEXX provides tests for monitoring and managing the health and productivity of livestock. IDEXX also provides tests for antibiotic residues and other contaminants in milk.